Alexion Pharmaceuticals
ALXN
#630
Rank
HK$315.38 B
Marketcap
HK$1,427
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Alexion Pharmaceuticals (ALXN)

Revenue in 2021 (TTM): HK$48.56 Billion

According to Alexion Pharmaceuticals's latest financial reports the company's current revenue is HK$48.94 Billion. In 2020 the company made a revenue of HK$47.45 Billion an increase over the revenue in the year 2019 that were of HK$39.01 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Alexion Pharmaceuticals from 2001 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)HK$48.56 B2.33%
2020HK$47.45 B21.63%
2019HK$39.01 B20.82%
2018HK$32.29 B16.36%
2017HK$27.75 B15.17%
2016HK$24.09 B18.42%
2015HK$20.34 B16.51%
2014HK$17.46 B43.99%
2013HK$12.12 B36.79%
2012HK$8.86 B44.76%
2011HK$6.12 B44.82%
2010HK$4.22 B39.85%
2009HK$3.02 B49.29%
2008HK$2.02 B259.66%
2007HK$0.56 B4523.88%
2006HK$12.18 M13.14%
2005HK$10.76 M-70.12%
2004HK$36.03 M557.49%
2003HK$5.48 M-85.98%
2002HK$39.08 M-50.6%
2001HK$79.11 M